123 related articles for article (PubMed ID: 12493785)
1. Effect of extended-spectrum beta-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins.
Tristram SG
J Antimicrob Chemother; 2003 Jan; 51(1):39-43. PubMed ID: 12493785
[TBL] [Abstract][Full Text] [Related]
2. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae.
Bozdogan B; Tristram S; Appelbaum PC
J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720
[TBL] [Abstract][Full Text] [Related]
3. Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae.
Karlowsky JA; Verma G; Zhanel GG; Hoban DJ
J Antimicrob Chemother; 2000 Jun; 45(6):871-5. PubMed ID: 10837442
[TBL] [Abstract][Full Text] [Related]
4. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013.
Skaare D; Anthonisen IL; Kahlmeter G; Matuschek E; Natås OB; Steinbakk M; Sundsfjord A; Kristiansen BE
Euro Surveill; 2014 Dec; 19(49):. PubMed ID: 25523969
[TBL] [Abstract][Full Text] [Related]
5. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method.
Ubukata K; Chiba N; Hasegawa K; Shibasaki Y; Sunakawa K; Nonoyama M; Iwata S; Konno M
J Infect Chemother; 2002 Mar; 8(1):50-8. PubMed ID: 11957120
[TBL] [Abstract][Full Text] [Related]
7. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
Tristram SG; Bozdogan B; Appelbaum PC
J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
Burns JL; Wong K; Smith AL
Infection; 1988; 16(5):293-6. PubMed ID: 3265130
[TBL] [Abstract][Full Text] [Related]
9. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
10. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
[TBL] [Abstract][Full Text] [Related]
11. Contribution of PBP3 Substitutions and TEM-1, TEM-15, and ROB-1 Beta-Lactamases to Cefotaxime Resistance in Haemophilus influenzae and Haemophilus parainfluenzae.
Søndergaard A; Nørskov-Lauritsen N
Microb Drug Resist; 2016 Jun; 22(4):247-52. PubMed ID: 26683319
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
[TBL] [Abstract][Full Text] [Related]
13. TEM-1 AND ROB-1 PRESENCE AND ANTIMICROBIAL RESISTANCE IN HAEMOPHILUS INFLUENZAE STRAINS, ISTANBUL, TURKEY.
Kuvat N; Nazik H; Berkiten R; Öngen B
Southeast Asian J Trop Med Public Health; 2015 Mar; 46(2):254-61. PubMed ID: 26513928
[TBL] [Abstract][Full Text] [Related]
14. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
Barry AL; Fuchs PC; Pfaller MA
Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
[TBL] [Abstract][Full Text] [Related]
16. Effect of cloned inhibitor-resistant TEM beta-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate.
Tristram SG; Burdach JG
J Antimicrob Chemother; 2007 Nov; 60(5):1151-4. PubMed ID: 17827143
[TBL] [Abstract][Full Text] [Related]
17. Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.
Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
J Antimicrob Chemother; 2005 Oct; 56(4):773-6. PubMed ID: 16096320
[TBL] [Abstract][Full Text] [Related]
18. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance and molecular epidemiology of the beta-lactamase-producing Haemophilus influenzae isolated in Chongqing, China.
Luo C; Xia Y; Liu Q; Chu L; Fu X; Jing C; Chen D; Liu L; Shi Y
APMIS; 2012 Nov; 120(11):926-34. PubMed ID: 23009117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
